#GP63
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin pubmed.ncbi.nlm.nih.gov/42619877/
August 21, 2026 at 7:31 PM
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin bioRxivpreprint
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin
The eukaryotic pathogen Leishmania major causes disfiguring cutaneous lesions, whose resolution can be complicated by secondary bacterial infections. Bacteria, including Aeromonas spp., also interact with L. major promastigotes in the sandfly midgut. The mechanisms by which L. major competes with bacteria and resists their toxins are poorly defined. Prior work proposed that L. major resists the Aeromonas-produced pore-forming toxin aerolysin using an altered GPI-anchor. However, we found that L. major is sensitive to aerolysin. Here, we determined the mechanism by which L. major promastigotes are sensitive to aerolysin, using flow cytometry and biochemical approaches to analyze promastigotes genetically deficient in enzymes that produce key membrane components. The virulence factor lipophosphoglycan protected L. major from aerolysin cytotoxicity. The metalloproteinase GP63 exerted the necessary furin-like protease activity to activate aerolysin. Leishmanial GPI-anchored proteins were necessary for aerolysin heptamerization and killing of L. major promastigotes. Finally, mutation of the GPI-anchor binding domain of aerolysin crippled its cytotoxicity, consistent with its reliance on the GPI-anchor binding site to engage GPI anchors on the surface of L. major promastigotes. Taken together, we propose the L. major virulence factor lipophosphoglycan defends against pore-forming toxins made by bacterial competitors, while the GP63 metalloproteinase activates pro-aerolysin like furin. Overall, this study highlights approaches microbes use to compete with each other.
dlvr.it
July 31, 2026 at 9:37 PM
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin www.biorxiv.org/content/10.64898/2026.07.29.741567v1
July 31, 2026 at 7:15 AM
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin https://www.biorxiv.org/content/10.64898/2026.07.29.741567v1
July 30, 2026 at 2:30 PM
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin https://www.biorxiv.org/content/10.64898/2026.07.29.741567v1
July 30, 2026 at 2:30 PM
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin bioRxivpreprint
Leishmanial GP63 acts as a protease for the small pore forming toxin aerolysin
The eukaryotic pathogen Leishmania major causes disfiguring cutaneous lesions, whose resolution can be complicated by secondary bacterial infections. Bacteria, including Aeromonas spp., also interact with L. major promastigotes in the sandfly midgut. The mechanisms by which L. major competes with bacteria and resists their toxins are poorly defined. Prior work proposed that L. major resists the Aeromonas-produced pore-forming toxin aerolysin using an altered GPI-anchor. However, we found that L. major is sensitive to aerolysin. Here, we determined the mechanism by which L. major promastigotes are sensitive to aerolysin, using flow cytometry and biochemical approaches to analyze promastigotes genetically deficient in enzymes that produce key membrane components. The virulence factor lipophosphoglycan protected L. major from aerolysin cytotoxicity. The metalloproteinase GP63 exerted the necessary furin-like protease activity to activate aerolysin. Leishmanial GPI-anchored proteins were necessary for aerolysin heptamerization and killing of L. major promastigotes. Finally, mutation of the GPI-anchor binding domain of aerolysin crippled its cytotoxicity, consistent with its reliance on the GPI-anchor binding site to engage GPI anchors on the surface of L. major promastigotes. Taken together, we propose the L. major virulence factor lipophosphoglycan defends against pore-forming toxins made by bacterial competitors, while the GP63 metalloproteinase activates pro-aerolysin like furin. Overall, this study highlights approaches microbes use to compete with each other.
dlvr.it
July 30, 2026 at 2:36 PM
Corrigendum to "Expression profiling of GP63 isoforms with predicted nuclear localization signals in Leishmania (Viannia) braziliensis" [Experimental Parasitology 286 (2026) 109155] PubMed
Corrigendum to "Expression profiling of GP63 isoforms with predicted nuclear localization signals in Leishmania (Viannia) braziliensis" [Experimental Parasitology 286 (2026) 109155]
No abstract
dlvr.it
June 12, 2026 at 10:45 AM
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms bioRxivpreprint
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms
Leishmania donovani (Ld), the etiological agent of visceral leishmaniasis, poses a significant global health burden due to its complex dixenous lifecycle involving both insect vectors and mammalian hosts. Successful infection in mammals requires the coordinated activity of stage-specific virulence factors. The zinc metalloprotease glycoprotease 63 (GP63) is a well-established virulence determinant critical for host cell attachment and invasion by insect-stage promastigotes. For humans, subsequent parasite propagation depends exclusively on intracellular amastigotes arising from lysed macrophages. Classical GP63 expression and function in Ld amastigotes remain poorly understood, and GP63 null mutants reportedly retain infectivity in mice, raising fundamental questions about virulence factor complementation during mammalian infection. By employing comparative transcriptomics, CRISPR-based mutagenesis, complemented with cell biology, and biochemical assays, this work identifies and characterizes multiple Ld GP63 paralogues with distinct roles in mammalian infection. While both copies of GP63 encoded on chromosome 10 (LdGP63_10.51 and 10.52) were functionally redundant, LdGP63_28 encoded on chromosome 28 proved essential for intracellular amastigote survival by suppressing host cell pyroptosis. Moreover, LdGP63_31 (chromosome 31) was found to primarily mediate promastigote attachment to the host macrophages with minimal contribution from LdGP63_28, facilitating initial infection establishment and amastigote genesis. Importantly, the absence of LdGP63_28 impacted amastigote infection more severely as compared to LdGP63_31. Structural and enzymatic analyses revealed divergent localization and substrate specificities to fulfil functional requirement of these divergent proteases, which have evolved independently to carry out diverse function in establishing infection. Collectively, this study indicates evolutionary divergence and functional specialization among GP63 isoforms in Ld by demonstrating that amastigote-specific and promastigote-specific GP63 isoforms synergistically mediate infection establishment and persistence.
dlvr.it
November 11, 2025 at 11:20 AM
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms bioRxivpreprint
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms
Leishmania donovani (Ld), the etiological agent of visceral leishmaniasis, poses a significant global health burden due to its complex dixenous lifecycle involving both insect vectors and mammalian hosts. Successful infection in mammals requires the coordinated activity of stage-specific virulence factors. The zinc metalloprotease glycoprotease 63 (GP63) is a well-established virulence determinant critical for host cell attachment and invasion by insect-stage promastigotes. For humans, subsequent parasite propagation depends exclusively on intracellular amastigotes arising from lysed macrophages. Classical GP63 expression and function in Ld amastigotes remain poorly understood, and GP63 null mutants reportedly retain infectivity in mice, raising fundamental questions about virulence factor complementation during mammalian infection. By employing comparative transcriptomics, CRISPR-based mutagenesis, complemented with cell biology, and biochemical assays, this work identifies and characterizes multiple Ld GP63 paralogues with distinct roles in mammalian infection. While both copies of GP63 encoded on chromosome 10 (LdGP63_10.51 and 10.52) were functionally redundant, LdGP63_28 encoded on chromosome 28 proved essential for intracellular amastigote survival by suppressing host cell pyroptosis. Moreover, LdGP63_31 (chromosome 31) was found to primarily mediate promastigote attachment to the host macrophages with minimal contribution from LdGP63_28, facilitating initial infection establishment and amastigote genesis. Importantly, the absence of LdGP63_28 impacted amastigote infection more severely as compared to LdGP63_31. Structural and enzymatic analyses revealed divergent localization and substrate specificities to fulfil functional requirement of these divergent proteases, which have evolved independently to carry out diverse function in establishing infection. Collectively, this study indicates evolutionary divergence and functional specialization among GP63 isoforms in Ld by demonstrating that amastigote-specific and promastigote-specific GP63 isoforms synergistically mediate infection establishment and persistence.
dlvr.it
November 10, 2025 at 4:19 AM
Exploring the Genomic Landscape of the GP63 family in Trypanosoma cruzi: Evolutionary Dynamics and Functional Peculiarities https://www.biorxiv.org/content/10.1101/2024.02.17.580826v1
Exploring the Genomic Landscape of the GP63 family in Trypanosoma cruzi: Evolutionary Dynamics and Functional Peculiarities https://www.biorxiv.org/content/10.1101/2024.02.17.580826v1
In the present work we analyzed the complete set of GP63 sequences from the parasitic protozoa Trypa
www.biorxiv.org
February 21, 2024 at 4:40 AM
LG Discounts 35% Off This Popular 34" LG UltraGear Gaming Monitor With Coupon Code
For three days, LG has marked down the popular 34" LG UltraGear 34GP63A gaming monitor by 35% off. It's normally priced at $399.99, but today you can get it from LG for only $259.99 after a 35% off coupon code "**ULTRA35** ". The GP63 has all the features you'd want in a gaming monitor, like a big ultrawide form factor, sharp resolution, fast response time, high refresh rate, wide viewing angles, and accurate color reproduction, all at an affordable price. ## 34" LG UltraGear Ultrawide Gaming Monitor for $259.99 The LG GP63A is a generously sized 34" curved display with a 3440x1440 ultra-wide resolution. Although it's not a true 4K monitor, it's still very sharp for just about any use case. In fact the pixel density (ppi) is identical to a 27" QHD monitor, which is considered the gold standard in terms of screen size to resolution. There's also another benefit; a 1440p resolution is less taxing on your GPU than 4K, so you can get away with a cheaper video card like an RTX 4060 or 4070. The GP63A is equipped with a VA panel with a sub-1ms response time and 99% sRGB color gamut. It has wide viewing angles and a more uniform backlighting (less hotspots on a black screen) than an IPS panel. It supports VRR and MBR and is FreeSync Premium certified. Although it isn't officially G-SYNC certified, it is G-SYNC compatible just like every other FreeSync monitor. There are DisplayPort and HDMI ports, but you'll want to use DisplayPort for the 160Hz refresh rate. If you're specifically looking for this size and aspect ratio, the GP63A is a great option. This has been one of LG's best selling 34" monitors for a long time and for good reason. It offers great features at a fair price that is made even better with this 35% off coupon. Nowadays monitor prices are getting out of hand with some top-end models selling for over $1500, potentially more expensive than your entire gaming setup. Don't hesiste, though, because this coupon ends soon. _Want more options? Check out our_ _favorite gaming monitors of 2024_ _._
www.ign.com
September 20, 2024 at 9:10 PM
A preprint using: Leishmania gp63 Mono (RRID:AB_934457) from @thermofishersci.bsky.social was published.

SciScore made a table with this resource, see “Automated Services” module (download as csv, xml or #jats) #methodsmatter #RRID
Leishmania secretory factor GP63 targets the DICER1/miR-122/hepcidin axis in host macrophages to deplete Nramp1
www.biorxiv.org
April 24, 2025 at 12:00 PM
Acheter (vraiment) moins cher GPS Takara GP63 europe 55,00 € livré #rueducommerce http://po.st/Kni2dd #super prix GPS écran digital 4.3
December 1, 2024 at 5:49 AM
📢 New Publication Alert!

We are thrilled to share our work on DNA Aptamers against Leishmania infantum GP63. New doors are opening for therapeutic and diagnostic tools! 🦟💊

Read more in Pharmaceutics: doi.org/10.3390/pharmaceutics18030304

@ibecbarcelona.eu @isglobal.org
April 24, 2026 at 4:50 AM
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms https://www.biorxiv.org/content/10.1101/2025.11.09.687440v1
November 10, 2025 at 4:18 AM
Corrigendum to "Expression profiling of GP63 isoforms with predicted nuclear localization signals in Leishmania (Viannia) braziliensis" [Experimental Parasitology 286 (2026) 109155] pubmed.ncbi.nlm.nih.gov/42276933/
June 12, 2026 at 11:27 AM
Expression Profiling of GP63 Isoforms with Predicted Nuclear Localization Signals in Leishmania (Viannia) braziliensis pubmed.ncbi.nlm.nih.gov/42214804/
May 30, 2026 at 12:47 PM
Development of DNA Aptamers Against Leishmania infantum GP63 Protein for Therapeutic and Diagnostic Applications pubmed.ncbi.nlm.nih.gov/41900790/
March 30, 2026 at 1:50 AM
Development of DNA Aptamers Against Leishmania infantum GP63 Protein for Therapeutic and Diagnostic Applications pubmed.ncbi.nlm.nih.gov/41900790/
March 29, 2026 at 4:06 PM
GP63 Alters the Macrophage Golgin160-Associated PIST Distribution by Reducing Caspase-3 Expression during Leishmania major Infection pubmed.ncbi.nlm.nih.gov/41269215/
November 22, 2025 at 8:38 PM
GP63 Alters the Macrophage Golgin160-Associated PIST Distribution by Reducing Caspase-3 Expression during Leishmania major Infection pubmed.ncbi.nlm.nih.gov/41269215/
November 22, 2025 at 5:06 PM
Detection of LPG2 and GP63 genes sequencing in patients with cutaneous leishmaniasis pubmed.ncbi.nlm.nih.gov/41230272/
November 14, 2025 at 1:34 PM
Synergy unleashed: Leishmania donovani GP63 paralogues cooperatively function to drive parasite infectivity at various pathogenic stages and regulate host survival mechanisms www.biorxiv.org/content/10.1101/2025.11.09.687440v1
November 10, 2025 at 8:15 AM
Leishmania-secreted GP63 targets DICER1/miR-122/hepcidin axis in host macrophages to deplete Nramp1 pubmed.ncbi.nlm.nih.gov/41135672/
October 25, 2025 at 3:29 PM